To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SPATS2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
248 supporting clones for gene SPATS2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AL833614 human endometrium carcinoma cell line .a 1 to 3317 3 to 3318 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 3318/3318
(100 %)
5 diff
(99.9 %id)
DB091262 testis .a 218 to 788 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
CN392075 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1 to 688 1 to 688   tiling clone,   688/688
(100 %)
0 diff
(100 %id)
BP313934 mammary gland .b 66 to 648 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
CN392066 embryonic stem cells, cell lines H1, H7, andH9 .b 82 to 779 1 to 698       698/698
(100 %)
1 diff
(99.9 %id)
BP341886 stomach mucosa .b 83 to 664 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BC048299 Uterus, leiomyosarcoma .b 87 to 2760 1 to 2674 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 2674/2674
(100 %)
0 diff
(100 %id)
BM542828 leiomyosarcoma, uterus .b 87 to 839 1 to 772       772/1052
(73 %)
22 diff
(98.0 %id)
CN392071 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 96 to 702 1 to 607       607/607
(100 %)
0 diff
(100 %id)
AK292334 testis .b 117 to 2205 1 to 2089 exact     2089/2089
(100 %)
1 diff
(100.0 %id)
DB042752 testis .b 118 to 692 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BU162697 large cell carcinoma, lung .b 136 to 659 1 to 524       524/893
(58 %)
2 diff
(99.8 %id)
CX164233 human embryonic stem cells differentiated toan early endodermal cell type .b 144 to 964 1 to 821       821/821
(100 %)
0 diff
(100 %id)
BX648916 human endometrium .b 145 to 3239 1 to 3098 H133P V134C N135Q G136W A137C ... tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 3098/3098
(100 %)
4 diff
(99.9 %id)
CN392073 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 145 to 788 1 to 644       644/644
(100 %)
2 diff
(99.7 %id)
AW403581 lymph .b 153 to 657 8 to 512       505/512
(98 %)
7 diff
(98.7 %id)
TI_154140297   .b 153 to 849 80 to 770       691/716
(96 %)
26 diff
(96.4 %id)
NM_023071.3   .c 1 to 3795 2 to 3796 exact RefSeq,   3796/3796
(100 %)
0 diff
(100 %id)
DA490422 brain .c 1 to 483 2 to 484   tiling clone, capped   483/483
(100 %)
0 diff
(100 %id)
DB063197 testis .c 25 to 468 2 to 447   capped   446/446
(100 %)
4 diff
(99.2 %id)
DB468968 hippocampus .c 399 to 820 1 to 423       423/423
(100 %)
2 diff
(99.6 %id)
DA805277 brain .c 422 to 991 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
AL536816 brain, fetal brain .c 434 to 1384 1 to 951       951/951
(100 %)
2 diff
(99.8 %id)
BI460611 testis .c 530 to 1262 1 to 737       737/839
(87 %)
16 diff
(98.1 %id)
BI458998 testis .c 561 to 1137 1 to 575       575/575
(100 %)
14 diff
(97.6 %id)
DA739695   .c 561 to 1066 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
CN421379 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 574 to 1247 1 to 674       674/674
(100 %)
2 diff
(99.8 %id)
DA575920   .c 600 to 1152 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA687068   .c 601 to 1151 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
AU131771   .c 602 to 1355 2 to 756   capped   755/760
(99 %)
11 diff
(98.6 %id)
DA758378   .c 602 to 1146 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA990829 synovial membrane tissue from rheumatioidarthritis .c 602 to 1138 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
AK023202   .c 605 to 3597 5 to 2996 G514R available from FLJ,   2992/2992
(100 %)
9 diff
(99.7 %id)
BI553702 brain, hippocampus .c 605 to 1374 1 to 771       771/775
(99 %)
11 diff
(98.6 %id)
BP288454 lung .c 608 to 1190 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA778590 brain .c 609 to 1178 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
TI_44168047   .c 610 to 1374 129 to 894       766/898
(85 %)
13 diff
(98.6 %id)
DA711770   .c 622 to 1185 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
AI681545 carcinoid, lung .c 673 to 1242 570 to 1       570/570
(100 %)
1 diff
(99.9 %id)
AI951714 fibrotheoma, ovary .c 683 to 1252 574 to 5       568/574
(98 %)
0 diff
(100 %id)
AL558178 T cells from T cell leukemia .c 735 to 1619 1 to 876       876/903
(97 %)
13 diff
(98.6 %id)
CR613910 T cells (Jurkat cell line) Cot10-normalized .c 736 to 2706 1 to 1971 exact     1971/1971
(100 %)
0 diff
(100 %id)
CB123861 Liver .c 736 to 1175 23 to 464       442/464
(95 %)
7 diff
(98.5 %id)
FN062899 breast carcinoma .c 742 to 834 1 to 95       95/95
(100 %)
5 diff
(94.8 %id)
AI570397 anaplastic oligodendroglioma, brain .c 746 to 1255 510 to 1       510/514
(99 %)
1 diff
(99.9 %id)
AW873588 pooled .c 755 to 1243 489 to 1       489/489
(100 %)
0 diff
(100 %id)
EC441002 Prostate .c 771 to 869 101 to 2       100/101
(99 %)
0 diff
(100 %id)
AA836396 germinal center B cell .c 799 to 1251 454 to 2       453/454
(99 %)
0 diff
(100 %id)
AI359986 anaplastic oligodendroglioma, brain .c 808 to 1255 448 to 1       448/448
(100 %)
0 diff
(100 %id)
BF000054 colon, colon tumor, RER+ .c 829 to 1250 424 to 2       423/424
(99 %)
1 diff
(99.8 %id)
BF108500 carcinoid, lung .c 844 to 1245 403 to 2       402/403
(99 %)
0 diff
(100 %id)
BF941023 brain, oligodendroglioma .c 852 to 1246 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AI499790 anaplastic oligodendroglioma, brain .c 859 to 1255 394 to 1       394/394
(100 %)
11 diff
(97.3 %id)
AU125443   .c 866 to 1693 2 to 829   capped   828/829
(99 %)
2 diff
(99.8 %id)
AA773477 lung, lung carcinoma .c 869 to 1256 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AI951615 fibrotheoma, ovary .c 882 to 1252 371 to 1       371/371
(100 %)
1 diff
(99.8 %id)
CN392072 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 891 to 1584 1 to 694       694/694
(100 %)
5 diff
(99.3 %id)
BF508132   .c 891 to 1258 382 to 5   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 387/382
(101 %)
49 diff
(87.2 %id)
BU161571 melanotic melanoma, skin .c 895 to 1693 1 to 809       809/899
(89 %)
28 diff
(96.9 %id)
T07547   .c 898 to 1231 334 to 1       334/334
(100 %)
0 diff
(100 %id)
DA020381   .c 901 to 1469 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA775719 brain .c 909 to 1487 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA538661 Kidney .c 916 to 1481 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AW304709 brain, three pooled meningiomas .c 924 to 1255 332 to 1       332/332
(100 %)
0 diff
(100 %id)
AB075515   .c 972 to 3602 1 to 2631 exact tiling clone,   2631/2631
(100 %)
0 diff
(100 %id)
BP205081 coronary artery .c 979 to 1558 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
AU124518   .c 979 to 1741 2 to 764   capped   763/764
(99 %)
5 diff
(99.4 %id)
DA775829 brain .c 1019 to 1587 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA534247 brain .c 1029 to 1576 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA785773 brain .c 1030 to 1611 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
BP383670   .c 1060 to 1541 1 to 483       483/499
(96 %)
4 diff
(99.2 %id)
BM012167 brain, neuroblastoma, cell line .c 1088 to 1820 1 to 735       735/761
(96 %)
13 diff
(98.3 %id)
BM012307 brain, neuroblastoma, cell line .c 1088 to 1668 1 to 580       580/583
(99 %)
3 diff
(99.5 %id)
TI_59381514   .c 1088 to 1668 105 to 684       580/583
(99 %)
3 diff
(99.5 %id)
TI_59381369   .c 1089 to 1820 92 to 825       734/760
(96 %)
12 diff
(98.5 %id)
AK023179   .c 1091 to 3795 1 to 2706   available from FLJ,   2706/2706
(100 %)
4 diff
(99.9 %id)
AU131371   .c 1092 to 1879 2 to 787   capped   788/787
(100 %)
9 diff
(98.9 %id)
AU131486   .c 1092 to 1811 2 to 716   capped   715/774
(92 %)
7 diff
(99.1 %id)
DA612811   .c 1113 to 1658 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
AF114041 brain .c 1115 to 1478 1 to 364       364/364
(100 %)
6 diff
(98.4 %id)
BQ879622 dorsal root ganglia .c 1157 to 1964 1 to 816       816/981
(83 %)
18 diff
(98.2 %id)
BE176629 head_neck .c 1201 to 1860 20 to 677       658/677
(97 %)
7 diff
(99.0 %id)
BX091983 whole brain .c 1206 to 1741 1 to 536       534/536
(99 %)
4 diff
(99.3 %id)
Z44580 brain, total brain .c 1207 to 1546 1 to 341       341/341
(100 %)
5 diff
(98.6 %id)
BM828628 Ascites, stomach .c 1207 to 1678 1 to 472       472/472
(100 %)
0 diff
(100 %id)
H10602 whole brain .c 1212 to 1692 1 to 502       502/505
(99 %)
40 diff
(92.1 %id)
BG827098 muscle, rhabdomyosarcoma .c 1255 to 1812 1 to 576       576/832
(69 %)
29 diff
(96.6 %id)
T30422 colon, endothelial .c 1269 to 1741 1 to 479       479/479
(100 %)
10 diff
(98.0 %id)
DA253673 caudate nucleus .c 1275 to 1849 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BQ712594 Spleen .c 1275 to 1836 3 to 568       566/870
(65 %)
20 diff
(97.8 %id)
DW426177 Liver .c 1276 to 1542 17 to 283       267/283
(94 %)
7 diff
(97.6 %id)
DA794623 brain .c 1276 to 1822 2 to 550   capped   549/549
(100 %)
3 diff
(99.5 %id)
AU130648   .c 1277 to 2061 2 to 785   capped   784/784
(100 %)
5 diff
(99.4 %id)
BQ707498 Spleen .c 1287 to 2028 1 to 750       750/938
(79 %)
9 diff
(99.1 %id)
TI_154188358   .c 1292 to 2231 121 to 1053       933/934
(99 %)
24 diff
(97.5 %id)
BF738253 bladder_tumor .c 1313 to 1733 1 to 423       423/423
(100 %)
10 diff
(97.7 %id)
T32690 heart .c 1317 to 1545 1 to 229       229/229
(100 %)
0 diff
(100 %id)
AW953065   .c 1318 to 1879 1 to 571       571/648
(88 %)
12 diff
(98.2 %id)
BG028420 Bone, osteosarcoma, cell line .c 1337 to 1994 1 to 658       616/717
(85 %)
17 diff
(97.7 %id)
AV746519 Pituitary .c 1340 to 1681 1 to 345       345/349
(98 %)
8 diff
(97.8 %id)
BF308887 muscle, rhabdomyosarcoma .c 1355 to 2099 1 to 744       744/823
(90 %)
35 diff
(95.8 %id)
BX328060   .c 1359 to 2102 1 to 752       752/890
(84 %)
17 diff
(98.1 %id)
DA808929 brain .c 1453 to 2024 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BM549283 melanotic melanoma, skin .c 1463 to 2300 1 to 852       852/962
(88 %)
26 diff
(97.3 %id)
BI860575 breast, mammary adenocarcinoma, cell line .c 1514 to 2318 1 to 803       803/803
(100 %)
12 diff
(98.6 %id)
TI_57189719   .c 1514 to 2318 52 to 854       803/803
(100 %)
12 diff
(98.6 %id)
DA069564 cerebellum .c 1646 to 2212 2 to 570   capped   569/569
(100 %)
4 diff
(99.3 %id)
AU134531 ovary, tumor tissue .c 1649 to 2411 14 to 781   capped   768/784
(97 %)
22 diff
(97.2 %id)
BG421923 Kidney, renal cell adenocarcinoma .c 1656 to 2457 1 to 778       778/927
(83 %)
32 diff
(96.6 %id)
BI439192 Pancreas, Purified pancreatic islet .c 1657 to 2237 11 to 591       581/591
(98 %)
7 diff
(98.9 %id)
BM717746 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1703 to 2323 1 to 621       621/621
(100 %)
2 diff
(99.7 %id)
AK024678   .c 1704 to 3785 1 to 2081   available from FLJ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2081/2081
(100 %)
3 diff
(99.9 %id)
BP203382 coronary artery .c 1704 to 2283 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
AU253656 neuroblastoma .c 1706 to 2313 1 to 606       606/647
(93 %)
14 diff
(97.9 %id)
BM503484 Pancreas, Purified pancreatic islet .c 1738 to 2287 1 to 550       550/550
(100 %)
0 diff
(100 %id)
BG927024 cartilage .c 1807 to 2150 86 to 429       344/361
(95 %)
7 diff
(98.1 %id)
AW366867 head_neck .c 1841 to 2087 1 to 246       246/246
(100 %)
7 diff
(97.2 %id)
BP291441 lung .c 1864 to 2292 1 to 429       429/584
(73 %)
12 diff
(98.0 %id)
CD631741   .c 1881 to 2201 1 to 321       321/327
(98 %)
9 diff
(97.3 %id)
CD674998 eye, lens .c 1883 to 2411 1 to 529       529/529
(100 %)
0 diff
(100 %id)
CD631740   .c 1884 to 2201 322 to 5       318/325
(97 %)
1 diff
(99.7 %id)
CN392068 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1884 to 2155 1 to 272       272/272
(100 %)
0 diff
(100 %id)
AL580069 T cells from T cell leukemia .c 1891 to 2696 819 to 11       808/875
(92 %)
26 diff
(97.1 %id)
BP194544 brain .c 1894 to 2468 1 to 576       574/581
(98 %)
9 diff
(98.5 %id)
TI_151754352   .c 1916 to 2731 870 to 60   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 811/932
(87 %)
11 diff
(98.9 %id)
AA135536.
matches multiple genes
uterus .c 1963 to 2553 1 to 601     also hits gene LAMA2 601/606
(99 %)
18 diff
(97.1 %id)
BM828501 Ascites, stomach .c 1972 to 2451 1 to 480       480/480
(100 %)
3 diff
(99.4 %id)
BU616758 Cell Line, Chondrosarcoma .c 1981 to 2731 769 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 751/751
(100 %)
1 diff
(99.9 %id)
BP268474 thyroid .c 2019 to 2572 1 to 554       554/554
(100 %)
6 diff
(99.0 %id)
BP268939 thyroid .c 2019 to 2598 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP269035 thyroid .c 2019 to 2597 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
BU633234 cell lines, Chondrosarcoma .c 2078 to 2755 697 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 679/679
(100 %)
1 diff
(99.9 %id)
CN392074 embryonic stem cells, cell lines H1, H7, andH9 .c 2154 to 2804 1 to 651       651/651
(100 %)
2 diff
(99.7 %id)
AL583538 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 2176 to 2735 1 to 560       560/560
(100 %)
0 diff
(100 %id)
AA135539 uterus .c 2185 to 2731 553 to 1       553/553
(100 %)
13 diff
(97.7 %id)
DB315368 brain .c 2192 to 2736 547 to 1       547/547
(100 %)
2 diff
(99.7 %id)
FN153275 breast carcinoma .c 2216 to 2317 102 to 5     Submitted on the opposite strand 98/102
(96 %)
0 diff
(100 %id)
BQ232691 large cell carcinoma, lung .c 2246 to 3103 1 to 863       863/863
(100 %)
7 diff
(99.2 %id)
AI498260 anaplastic oligodendroglioma, brain .c 2256 to 2735 482 to 2       481/482
(99 %)
0 diff
(100 %id)
AI288616 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2279 to 2731 453 to 1       453/453
(100 %)
0 diff
(100 %id)
H10393 whole brain .c 2294 to 2735 455 to 8       448/457
(98 %)
1 diff
(99.8 %id)
AW004721 colon .c 2301 to 2732 434 to 3       432/435
(99 %)
0 diff
(100 %id)
AI823893 2 pooled tumors (clear cell type), Kidney .c 2308 to 2742 450 to 16   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 435/435
(100 %)
6 diff
(98.7 %id)
AW044653 pooled .c 2308 to 2755 465 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 448/449
(99 %)
7 diff
(98.5 %id)
BQ233460 melanotic melanoma, skin .c 2308 to 3107 34 to 841       808/895
(90 %)
19 diff
(97.9 %id)
BG291015 bladder, transitional cell papilloma, cell line .c 2329 to 3047 18 to 732       715/738
(96 %)
6 diff
(99.2 %id)
CN392069 embryonic stem cells, DMSO-treated H9 cellline .c 2333 to 2938 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BE077277 breast .c 2390 to 2559 173 to 6     Submitted on the opposite strand 168/179
(93 %)
0 diff
(100 %id)
EC485501 Prostate .c 2402 to 2478 1 to 78       78/84
(92 %)
7 diff
(91.7 %id)
AI923329 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 2406 to 2731 326 to 1       326/326
(100 %)
0 diff
(100 %id)
AW135120   .c 2475 to 2737 285 to 21       265/285
(92 %)
0 diff
(100 %id)
Z40461 brain, total brain .c 2490 to 2734 245 to 1       245/245
(100 %)
1 diff
(99.6 %id)
DB362407   .c 2541 to 3087 558 to 1       558/563
(99 %)
23 diff
(96.0 %id)
AI791414 Kidney, kidney tumor .c 2594 to 3043 1 to 450       450/450
(100 %)
0 diff
(100 %id)
BE966800 melanotic melanoma, skin .c 2602 to 3306 723 to 15   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 709/850
(83 %)
37 diff
(95.7 %id)
AA304221 aorta .c 2629 to 2920 1 to 295       295/296
(99 %)
7 diff
(97.7 %id)
AW373518 breast .c 2653 to 3211 34 to 592       559/592
(94 %)
11 diff
(98.2 %id)
BM503322 Pancreas, Purified pancreatic islet .c 2693 to 3305 613 to 1       613/613
(100 %)
0 diff
(100 %id)
DT220307 brain .c 2723 to 3251 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BM272367 Pancreas, Purified pancreatic islet .c 2729 to 3250 1 to 522       522/522
(100 %)
2 diff
(99.7 %id)
DB363074   .c 2738 to 3299 562 to 1       562/570
(98 %)
12 diff
(97.9 %id)
AV705527 adrenal gland .c 2758 to 3320 1 to 563       563/571
(98 %)
4 diff
(99.3 %id)
AU155482 ovary, tumor tissue .c 2758 to 3306 548 to 1       548/557
(98 %)
13 diff
(97.7 %id)
AA365386 pineal body .c 2797 to 3192 1 to 399       399/399
(100 %)
8 diff
(98.0 %id)
AL566510 brain, fetal brain .c 2797 to 3757 964 to 1       964/964
(100 %)
19 diff
(98.1 %id)
AI733016 Kidney, kidney tumor .c 2806 to 3306 502 to 1       502/502
(100 %)
3 diff
(99.5 %id)
AW779703 Kidney .c 2821 to 3306 486 to 1       486/486
(100 %)
0 diff
(100 %id)
BE466476 Kidney .c 2843 to 3306 464 to 1       464/464
(100 %)
1 diff
(99.8 %id)
CK023990 brain/CNS, Human Brain - Frontal Cortex .c 2889 to 3530 1 to 640       640/731
(87 %)
12 diff
(98.4 %id)
AI368906 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 2902 to 3326 431 to 7       425/431
(98 %)
0 diff
(100 %id)
AU252665 neuroblastoma .c 2938 to 3613 695 to 20       676/700
(96 %)
0 diff
(100 %id)
AI273963 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 2945 to 3306 362 to 1       362/362
(100 %)
0 diff
(100 %id)
BF910528 uterus_tumor .c 2951 to 3279 1 to 331       331/331
(100 %)
7 diff
(97.9 %id)
TI_154154148   .c 2970 to 3597 725 to 100   AAA Submitted on the opposite strand 626/631
(99 %)
9 diff
(98.6 %id)
CV376549 uterus_tumor .c 3001 to 3214 208 to 9     Submitted on the opposite strand 200/208
(96 %)
0 diff
(100 %id)
AU153445   .c 3024 to 3597 571 to 1       571/571
(100 %)
18 diff
(96.9 %id)
AW023088 cochlea, ear .c 3039 to 3384 1 to 346       346/346
(100 %)
5 diff
(98.6 %id)
BU954286 mixed (pool of 40 RNAs) .c 3072 to 3776 1 to 709       709/786
(90 %)
8 diff
(99.0 %id)
AA937342 Kidney, kidney tumor .c 3078 to 3305 228 to 1       228/228
(100 %)
0 diff
(100 %id)
AW500029 lymph .c 3090 to 3597 534 to 27   AAA Submitted on the opposite strand 508/508
(100 %)
0 diff
(100 %id)
BF155541 head_neck .c 3096 to 3377 1 to 282       282/282
(100 %)
7 diff
(97.6 %id)
CN392067 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 3103 to 3757 11 to 667       657/667
(98 %)
7 diff
(99.0 %id)
BI438864 Pancreas, Purified pancreatic islet .c 3110 to 3598 489 to 1       489/489
(100 %)
1 diff
(99.8 %id)
AU253657 neuroblastoma .c 3130 to 3796 700 to 34       667/700
(95 %)
0 diff
(100 %id)
FN050108 breast carcinoma .c 3196 to 3280 1 to 85       85/86
(98 %)
1 diff
(98.9 %id)
AU152561   .c 3232 to 3785 554 to 1       554/556
(99 %)
2 diff
(99.7 %id)
AI865228 lymph node, lymphoma, follicular mixed small and largecell .c 3250 to 3308 59 to 1       59/59
(100 %)
0 diff
(100 %id)
AW190505 adenocarcinoma, Pancreas .c 3293 to 3795 514 to 12   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 503/503
(100 %)
6 diff
(98.9 %id)
DB536429 hippocampus .c 3345 to 3795 1 to 450   tiling clone, Submitted on the opposite strand 450/450
(100 %)
16 diff
(96.5 %id)
AU153211   .c 3347 to 3795 449 to 1       449/454
(98 %)
8 diff
(98.3 %id)
AU153114   .c 3500 to 3795 298 to 1       298/300
(99 %)
2 diff
(99.4 %id)
AW514542 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 3528 to 3788 265 to 7       259/265
(97 %)
0 diff
(100 %id)
EH341582   .c 3598 to 3694 16 to 111       96/111
(86 %)
6 diff
(94.6 %id)
C02109   .c 3680 to 3795 1 to 116       116/116
(100 %)
1 diff
(99.2 %id)
AK095582 brain .d 1 to 2780 2 to 2781 C248R tiling clone, available from FLJ,   2781/2781
(100 %)
2 diff
(100.0 %id)
BP289273 lung .d 1661 to 2235 1 to 575   tiling clone,   575/575
(100 %)
0 diff
(100 %id)
BE047679 brain, tumor, 5 pooled (see description) .d 1794 to 2233 1 to 440       440/440
(100 %)
0 diff
(100 %id)
AI863391 brain, tumor, 5 pooled (see description) .d 2959 to 3350 393 to 1   tiling clone,   393/395
(99 %)
1 diff
(99.8 %id)
DB121864 thymus .e 1 to 563 2 to 564   tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
DB344021 thymus .e 1874 to 2418 544 to 1   tiling clone,   544/544
(100 %)
4 diff
(99.3 %id)
CR746970 melanotic melanoma, skin .f 1 to 495 12 to 506   tiling clone,   495/514
(96 %)
8 diff
(98.5 %id)
BQ215926 melanotic melanoma, skin .f 4 to 823 1 to 828 K143E Q144T A145S F146P A147L ... tiling clone,   826/939
(87 %)
22 diff
(97.7 %id)
BF875185 lung_tumor .g 1 to 432 441 to 9   tiling clone, Submitted on the opposite strand 433/463
(93 %)
0 diff
(100 %id)
W87351 liver and spleen .g 288 to 593 1 to 308   tiling clone, fully sequenced,   308/308
(100 %)
3 diff
(99.1 %id)
W87496 liver and spleen .g 532 to 1022 509 to 16   tiling clone, fully sequenced,   494/509
(97 %)
4 diff
(99.3 %id)
DA027695   .h 1 to 579 2 to 580   tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
CN290573 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 376 to 876 1 to 502   tiling clone,   502/502
(100 %)
1 diff
(99.9 %id)
DA662412   .h 411 to 991 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
AL698117 human skeletal muscle .h 500 to 1223 1 to 725   tiling clone,   725/730
(99 %)
3 diff
(99.6 %id)
BX643071   .h 1092 to 1685 1 to 593   tiling clone,   593/593
(100 %)
1 diff
(99.9 %id)
BX643072   .h 1092 to 1484 9 to 400   tiling clone,   392/400
(98 %)
6 diff
(98.5 %id)
BF695711 brain, primitive neuroectoderm .h 1618 to 2323 1 to 681       681/800
(85 %)
39 diff
(95.2 %id)
AW501154 lymph .h 1654 to 2020 1 to 371   tiling clone,   371/371
(100 %)
8 diff
(97.9 %id)
CF121579 lymph .h 1654 to 2335 1 to 687       687/687
(100 %)
8 diff
(98.9 %id)
TI_154155739   .h 1660 to 2094 79 to 517       439/439
(100 %)
9 diff
(98.0 %id)
TI_154180741   .h 1660 to 2510 75 to 927       853/856
(99 %)
11 diff
(98.8 %id)
CN293884 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 1710 to 2312 1 to 605       605/605
(100 %)
2 diff
(99.7 %id)
BU949881 Pancreas, Purified pancreatic islet .h 1913 to 2526 1 to 614   tiling clone,   614/614
(100 %)
2 diff
(99.7 %id)
AI934130 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h 2178 to 2387 1 to 211     Submitted on the opposite strand 211/211
(100 %)
1 diff
(99.6 %id)
DB295717   .h 2394 to 2935 543 to 1   tiling clone,   543/543
(100 %)
1 diff
(99.9 %id)
AL696609 human skeletal muscle .h 2755 to 3328 1 to 575   tiling clone,   575/575
(100 %)
2 diff
(99.7 %id)
BU949598 Pancreas, Purified pancreatic islet .h 2775 to 2934 160 to 1       160/160
(100 %)
3 diff
(98.2 %id)
BP226209   .h 3327 to 3907 1 to 581 exact tiling clone,   581/581
(100 %)
0 diff
(100 %id)
BU154749 melanotic melanoma, skin .i 1 to 803 1 to 809 I138X N139H S148X E152G T153D ... tiling clone,   809/960
(84 %)
16 diff
(98.4 %id)
W04788 lung .j 1 to 440 6 to 448 S97K G98W Q99P P100A tiling clone,   448/448
(100 %)
11 diff
(97.6 %id)
BG389237 embryonal carcinoma, cell line, testis .k 1 to 829 1 to 826 I14H L55W Q56P H57A F58L ... tiling clone,   826/919
(89 %)
20 diff
(97.9 %id)
BU597167 mixed (pool of 40 RNAs) .l 1 to 705 1 to 709 exact tiling clone,   709/747
(94 %)
10 diff
(98.7 %id)
BG542701 lung .m 1 to 722 1 to 726 T82P K86H K87E K88Q V89R ... tiling clone, available from MGC,   726/727
(99 %)
28 diff
(96.2 %id)
BC017767 lung .m 2 to 1044 1 to 1043 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1043/1045
(99 %)
18 diff
(98.3 %id)
BP287624 lung .m 9 to 587 1 to 579       579/583
(99 %)
4 diff
(99.4 %id)
BX483076   .m 10 to 548 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
CK005274 brain/CNS, Human Brain - Frontal Cortex .m 118 to 712 70 to 665 exact tiling clone,   650/666
(97 %)
12 diff
(98.2 %id)
N29974 nose, olfactory epithelium .m 416 to 883 468 to 1   tiling clone,   468/476
(98 %)
11 diff
(97.7 %id)
CD703510 normal nasopharynx .m 484 to 996 22 to 534   tiling clone,   513/534
(96 %)
11 diff
(98.0 %id)
DB055657 testis .n 1 to 557 2 to 558 exact tiling clone, capped   557/557
(100 %)
0 diff
(100 %id)
BX644933   .o 1 to 503 4 to 506 exact tiling clone,   506/506
(100 %)
2 diff
(99.7 %id)
DB019869 testis .p 1 to 526 2 to 527 exact tiling clone, capped   526/526
(100 %)
0 diff
(100 %id)
DA789196 brain .q 1 to 481 2 to 484 Q41X tiling clone, capped   483/485
(99 %)
4 diff
(99.2 %id)
DN990791 brain, whole brain .r 1 to 564 9 to 572 exact tiling clone,   564/572
(98 %)
5 diff
(99.2 %id)
DB033886 testis .s 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
BC032441 Colon, Kidney, Stomach, adult, whole pooled .s 120 to 1928 1 to 1813 exact tiling clone, available from MGC, AAA   1813/1813
(100 %)
14 diff
(99.3 %id)
BI517324 pooled colon, kidney, stomach .s 120 to 848 1 to 729 exact available from MGC,   729/729
(100 %)
0 diff
(100 %id)
TI_45235540   .s 120 to 848 33 to 761 exact     729/761
(95 %)
6 diff
(99.3 %id)
ES608174 brain .s 1613 to 2668 1 to 1056   tiling clone,   1056/1056
(100 %)
2 diff
(99.9 %id)
BP358709 mammary gland .t 1 to 545 6 to 553 exact tiling clone,   553/581
(95 %)
17 diff
(97.1 %id)
CA418208 Bone, Human Chondrosarcoma Cell Line .t 405 to 1087 19 to 701   tiling clone, Submitted on the opposite strand 683/683
(100 %)
0 diff
(100 %id)
DN999870   .u 1 to 656 1 to 656   tiling clone,   656/656
(100 %)
7 diff
(99.0 %id)
AA584308 colon, colon tumor RER+ .u 218 to 800 584 to 1 exact tiling clone,   584/584
(100 %)
1 diff
(99.9 %id)
DA568001 whole embryo, mainly head .va 1 to 682 2 to 684 A34G N35X C40V L41S Y42T tiling clone, capped   683/749
(91 %)
17 diff
(97.8 %id)
BU166139 melanotic melanoma, skin .vb 1 to 654 5 to 659 exact tiling clone,   655/914
(71 %)
16 diff
(98.3 %id)
DW418008 Liver .vb 405 to 637 18 to 250   tiling clone, AAA   233/250
(93 %)
7 diff
(97.2 %id)
DB086986 testis .vc 1 to 554 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB086992 testis .vc 1 to 569 2 to 570 exact tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
DA908326   .vd 1 to 561 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
DA508570 brain .ve 1 to 554 2 to 555 exact tiling clone, capped   554/554
(100 %)
0 diff
(100 %id)
AA774105   .vf-u 1 to 443 443 to 1 L10W V11* tiling clone,   443/443
(100 %)
7 diff
(98.5 %id)
CN392070 embryonic stem cells, cell lines H1, H7, andH9 .vg 1 to 401 1 to 401 exact tiling clone,   401/401
(100 %)
2 diff
(99.6 %id)
BE146589 head_neck Gene SPATS2, variant not shown              
DB305045 brain Gene SPATS2, variant not shown              
DA222330 brain Gene SPATS2, variant not shown       capped      
CN287999 embryonic stem cells, cell lines H1, H7, andH9 Gene SPATS2, variant not shown              
AV691697 hepatocellular carcinoma Gene SPATS2, variant not shown         Suspected internal deletion, this clone was ignored    
AV646767 corresponding non cancerous liver tissue Gene SPATS2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
T67064 liver and spleen Gene SPATS2, variant not shown              
T67065 liver and spleen Gene SPATS2, variant not shown              
BF434213 Kidney Gene SPATS2, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf-u, .vg Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C